The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Veterinary Clostridium Vaccine-Global Market Insights and Sales Trends 2024
Synopsis
A clostridial vaccine is a vaccine for sheep and cattle that protects against diseases caused by toxins produced by an infection with one or more Clostridium bacteria.
The global Veterinary Clostridium Vaccine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Veterinary Clostridium Vaccine in various end use industries. The expanding demands from the Veterinary Clinic, Veterinary Hospital, Veterinary Research Institute and Retail Pharmacy, are propelling Veterinary Clostridium Vaccine market. Bovine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ovine segment is estimated at % CAGR for the next seven-year period.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 105%.
Report Objectives
This report provides market insight on the different segments, by players, by Objects, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Veterinary Clostridium Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Veterinary Clostridium Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Veterinary Clostridium Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Veterinary Clostridium Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Veterinary Clostridium Vaccine covered in this report include Elanco, Merck, Merial, Zoetis, Advaxis, Ampliphi, Aratana Therapeutics, ARKO Labs and Bayer, etc.
The global Veterinary Clostridium Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Elanco
Merck
Merial
Zoetis
Advaxis
Ampliphi
Aratana Therapeutics
ARKO Labs
Bayer
CanFel Therapeutics
Ceva
Colorado Serum
Epitopix
Genus
Hygieia Biological Laboratories
Nexvet
Nuovo Biologics
Valneva
Vetoquinol
Virbac
Global Veterinary Clostridium Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Veterinary Clostridium Vaccine market, Segment by Objects:
Bovine
Ovine
Caprine
Swine
Poultry
Global Veterinary Clostridium Vaccine market, by Application
Veterinary Clinic
Veterinary Hospital
Veterinary Research Institute
Retail Pharmacy
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Objects, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Veterinary Clostridium Vaccine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
A clostridial vaccine is a vaccine for sheep and cattle that protects against diseases caused by toxins produced by an infection with one or more Clostridium bacteria.
The global Veterinary Clostridium Vaccine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Veterinary Clostridium Vaccine in various end use industries. The expanding demands from the Veterinary Clinic, Veterinary Hospital, Veterinary Research Institute and Retail Pharmacy, are propelling Veterinary Clostridium Vaccine market. Bovine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ovine segment is estimated at % CAGR for the next seven-year period.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 105%.
Report Objectives
This report provides market insight on the different segments, by players, by Objects, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Veterinary Clostridium Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Veterinary Clostridium Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Veterinary Clostridium Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Veterinary Clostridium Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Veterinary Clostridium Vaccine covered in this report include Elanco, Merck, Merial, Zoetis, Advaxis, Ampliphi, Aratana Therapeutics, ARKO Labs and Bayer, etc.
The global Veterinary Clostridium Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Elanco
Merck
Merial
Zoetis
Advaxis
Ampliphi
Aratana Therapeutics
ARKO Labs
Bayer
CanFel Therapeutics
Ceva
Colorado Serum
Epitopix
Genus
Hygieia Biological Laboratories
Nexvet
Nuovo Biologics
Valneva
Vetoquinol
Virbac
Global Veterinary Clostridium Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Veterinary Clostridium Vaccine market, Segment by Objects:
Bovine
Ovine
Caprine
Swine
Poultry
Global Veterinary Clostridium Vaccine market, by Application
Veterinary Clinic
Veterinary Hospital
Veterinary Research Institute
Retail Pharmacy
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Objects, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Veterinary Clostridium Vaccine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Veterinary Clostridium Vaccine
1.1 Veterinary Clostridium Vaccine Market Overview
1.1.1 Veterinary Clostridium Vaccine Product Scope
1.1.2 Veterinary Clostridium Vaccine Market Status and Outlook
1.2 Global Veterinary Clostridium Vaccine Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Veterinary Clostridium Vaccine Market Size by Region (2018-2029)
1.4 Global Veterinary Clostridium Vaccine Historic Market Size by Region (2018-2023)
1.5 Global Veterinary Clostridium Vaccine Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Veterinary Clostridium Vaccine Market Size (2018-2029)
1.6.1 North America Veterinary Clostridium Vaccine Market Size (2018-2029)
1.6.2 Europe Veterinary Clostridium Vaccine Market Size (2018-2029)
1.6.3 Asia-Pacific Veterinary Clostridium Vaccine Market Size (2018-2029)
1.6.4 Latin America Veterinary Clostridium Vaccine Market Size (2018-2029)
1.6.5 Middle East & Africa Veterinary Clostridium Vaccine Market Size (2018-2029)
2 Veterinary Clostridium Vaccine Market by Objects
2.1 Introduction
2.1.1 Bovine
2.1.2 Ovine
2.1.3 Caprine
2.1.4 Swine
2.1.5 Poultry
2.2 Global Veterinary Clostridium Vaccine Market Size by Objects: 2018 VS 2022 VS 2029
2.2.1 Global Veterinary Clostridium Vaccine Historic Market Size by Objects (2018-2023)
2.2.2 Global Veterinary Clostridium Vaccine Forecasted Market Size by Objects (2024-2029)
2.3 Key Regions Market Size by Objects
2.3.1 North America Veterinary Clostridium Vaccine Revenue Breakdown by Objects (2018-2029)
2.3.2 Europe Veterinary Clostridium Vaccine Revenue Breakdown by Objects (2018-2029)
2.3.3 Asia-Pacific Veterinary Clostridium Vaccine Revenue Breakdown by Objects (2018-2029)
2.3.4 Latin America Veterinary Clostridium Vaccine Revenue Breakdown by Objects (2018-2029)
2.3.5 Middle East and Africa Veterinary Clostridium Vaccine Revenue Breakdown by Objects (2018-2029)
3 Veterinary Clostridium Vaccine Market Overview by Application
3.1 Introduction
3.1.1 Veterinary Clinic
3.1.2 Veterinary Hospital
3.1.3 Veterinary Research Institute
3.1.4 Retail Pharmacy
3.1.5 Others
3.2 Global Veterinary Clostridium Vaccine Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Veterinary Clostridium Vaccine Historic Market Size by Application (2018-2023)
3.2.2 Global Veterinary Clostridium Vaccine Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Veterinary Clostridium Vaccine Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Veterinary Clostridium Vaccine Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Veterinary Clostridium Vaccine Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Veterinary Clostridium Vaccine Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Veterinary Clostridium Vaccine Revenue Breakdown by Application (2018-2029)
4 Veterinary Clostridium Vaccine Competition Analysis by Players
4.1 Global Veterinary Clostridium Vaccine Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Veterinary Clostridium Vaccine as of 2022)
4.3 Date of Key Players Enter into Veterinary Clostridium Vaccine Market
4.4 Global Top Players Veterinary Clostridium Vaccine Headquarters and Area Served
4.5 Key Players Veterinary Clostridium Vaccine Product Solution and Service
4.6 Competitive Status
4.6.1 Veterinary Clostridium Vaccine Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Elanco
5.1.1 Elanco Profile
5.1.2 Elanco Main Business
5.1.3 Elanco Veterinary Clostridium Vaccine Products, Services and Solutions
5.1.4 Elanco Veterinary Clostridium Vaccine Revenue (US$ Million) & (2018-2023)
5.1.5 Elanco Recent Developments
5.2 Merck
5.2.1 Merck Profile
5.2.2 Merck Main Business
5.2.3 Merck Veterinary Clostridium Vaccine Products, Services and Solutions
5.2.4 Merck Veterinary Clostridium Vaccine Revenue (US$ Million) & (2018-2023)
5.2.5 Merck Recent Developments
5.3 Merial
5.3.1 Merial Profile
5.3.2 Merial Main Business
5.3.3 Merial Veterinary Clostridium Vaccine Products, Services and Solutions
5.3.4 Merial Veterinary Clostridium Vaccine Revenue (US$ Million) & (2018-2023)
5.3.5 Zoetis Recent Developments
5.4 Zoetis
5.4.1 Zoetis Profile
5.4.2 Zoetis Main Business
5.4.3 Zoetis Veterinary Clostridium Vaccine Products, Services and Solutions
5.4.4 Zoetis Veterinary Clostridium Vaccine Revenue (US$ Million) & (2018-2023)
5.4.5 Zoetis Recent Developments
5.5 Advaxis
5.5.1 Advaxis Profile
5.5.2 Advaxis Main Business
5.5.3 Advaxis Veterinary Clostridium Vaccine Products, Services and Solutions
5.5.4 Advaxis Veterinary Clostridium Vaccine Revenue (US$ Million) & (2018-2023)
5.5.5 Advaxis Recent Developments
5.6 Ampliphi
5.6.1 Ampliphi Profile
5.6.2 Ampliphi Main Business
5.6.3 Ampliphi Veterinary Clostridium Vaccine Products, Services and Solutions
5.6.4 Ampliphi Veterinary Clostridium Vaccine Revenue (US$ Million) & (2018-2023)
5.6.5 Ampliphi Recent Developments
5.7 Aratana Therapeutics
5.7.1 Aratana Therapeutics Profile
5.7.2 Aratana Therapeutics Main Business
5.7.3 Aratana Therapeutics Veterinary Clostridium Vaccine Products, Services and Solutions
5.7.4 Aratana Therapeutics Veterinary Clostridium Vaccine Revenue (US$ Million) & (2018-2023)
5.7.5 Aratana Therapeutics Recent Developments
5.8 ARKO Labs
5.8.1 ARKO Labs Profile
5.8.2 ARKO Labs Main Business
5.8.3 ARKO Labs Veterinary Clostridium Vaccine Products, Services and Solutions
5.8.4 ARKO Labs Veterinary Clostridium Vaccine Revenue (US$ Million) & (2018-2023)
5.8.5 ARKO Labs Recent Developments
5.9 Bayer
5.9.1 Bayer Profile
5.9.2 Bayer Main Business
5.9.3 Bayer Veterinary Clostridium Vaccine Products, Services and Solutions
5.9.4 Bayer Veterinary Clostridium Vaccine Revenue (US$ Million) & (2018-2023)
5.9.5 Bayer Recent Developments
5.10 CanFel Therapeutics
5.10.1 CanFel Therapeutics Profile
5.10.2 CanFel Therapeutics Main Business
5.10.3 CanFel Therapeutics Veterinary Clostridium Vaccine Products, Services and Solutions
5.10.4 CanFel Therapeutics Veterinary Clostridium Vaccine Revenue (US$ Million) & (2018-2023)
5.10.5 CanFel Therapeutics Recent Developments
5.11 Ceva
5.11.1 Ceva Profile
5.11.2 Ceva Main Business
5.11.3 Ceva Veterinary Clostridium Vaccine Products, Services and Solutions
5.11.4 Ceva Veterinary Clostridium Vaccine Revenue (US$ Million) & (2018-2023)
5.11.5 Ceva Recent Developments
5.12 Colorado Serum
5.12.1 Colorado Serum Profile
5.12.2 Colorado Serum Main Business
5.12.3 Colorado Serum Veterinary Clostridium Vaccine Products, Services and Solutions
5.12.4 Colorado Serum Veterinary Clostridium Vaccine Revenue (US$ Million) & (2018-2023)
5.12.5 Colorado Serum Recent Developments
5.13 Epitopix
5.13.1 Epitopix Profile
5.13.2 Epitopix Main Business
5.13.3 Epitopix Veterinary Clostridium Vaccine Products, Services and Solutions
5.13.4 Epitopix Veterinary Clostridium Vaccine Revenue (US$ Million) & (2018-2023)
5.13.5 Epitopix Recent Developments
5.14 Genus
5.14.1 Genus Profile
5.14.2 Genus Main Business
5.14.3 Genus Veterinary Clostridium Vaccine Products, Services and Solutions
5.14.4 Genus Veterinary Clostridium Vaccine Revenue (US$ Million) & (2018-2023)
5.14.5 Genus Recent Developments
5.15 Hygieia Biological Laboratories
5.15.1 Hygieia Biological Laboratories Profile
5.15.2 Hygieia Biological Laboratories Main Business
5.15.3 Hygieia Biological Laboratories Veterinary Clostridium Vaccine Products, Services and Solutions
5.15.4 Hygieia Biological Laboratories Veterinary Clostridium Vaccine Revenue (US$ Million) & (2018-2023)
5.15.5 Hygieia Biological Laboratories Recent Developments
5.16 Nexvet
5.16.1 Nexvet Profile
5.16.2 Nexvet Main Business
5.16.3 Nexvet Veterinary Clostridium Vaccine Products, Services and Solutions
5.16.4 Nexvet Veterinary Clostridium Vaccine Revenue (US$ Million) & (2018-2023)
5.16.5 Nexvet Recent Developments
5.17 Nuovo Biologics
5.17.1 Nuovo Biologics Profile
5.17.2 Nuovo Biologics Main Business
5.17.3 Nuovo Biologics Veterinary Clostridium Vaccine Products, Services and Solutions
5.17.4 Nuovo Biologics Veterinary Clostridium Vaccine Revenue (US$ Million) & (2018-2023)
5.17.5 Nuovo Biologics Recent Developments
5.18 Valneva
5.18.1 Valneva Profile
5.18.2 Valneva Main Business
5.18.3 Valneva Veterinary Clostridium Vaccine Products, Services and Solutions
5.18.4 Valneva Veterinary Clostridium Vaccine Revenue (US$ Million) & (2018-2023)
5.18.5 Valneva Recent Developments
5.19 Vetoquinol
5.19.1 Vetoquinol Profile
5.19.2 Vetoquinol Main Business
5.19.3 Vetoquinol Veterinary Clostridium Vaccine Products, Services and Solutions
5.19.4 Vetoquinol Veterinary Clostridium Vaccine Revenue (US$ Million) & (2018-2023)
5.19.5 Vetoquinol Recent Developments
5.20 Virbac
5.20.1 Virbac Profile
5.20.2 Virbac Main Business
5.20.3 Virbac Veterinary Clostridium Vaccine Products, Services and Solutions
5.20.4 Virbac Veterinary Clostridium Vaccine Revenue (US$ Million) & (2018-2023)
5.20.5 Virbac Recent Developments
6 North America
6.1 North America Veterinary Clostridium Vaccine Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Veterinary Clostridium Vaccine Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Clostridium Vaccine Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Veterinary Clostridium Vaccine Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Clostridium Vaccine Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Veterinary Clostridium Vaccine Market Dynamics
11.1 Veterinary Clostridium Vaccine Industry Trends
11.2 Veterinary Clostridium Vaccine Market Drivers
11.3 Veterinary Clostridium Vaccine Market Challenges
11.4 Veterinary Clostridium Vaccine Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
